Cytokine activation of natural killer cells

  • Syh Jae Lin*
  • , Pei Tzu Lee
  • , Ming Ling Kuo
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

2 Scopus citations

Abstract

CD3CD56+ natural killer (NK) cells can kill various tumors in a non major histocompatibility complex (MHC)-restricted fashion. Recent advances have been made in the application of NK cells for the treatment of patients with acute myelogenous leukemia (AML). Allogeneic donor-derived NK cells can be activated in vitro and infused into patients receiving stem cell transplants. We describe in this chapter the method to activate NK cells with cytokines and to ascertain their degree of activation.

Original languageEnglish
Pages (from-to)223-229
Number of pages7
JournalMethods in Molecular Biology
Volume1139
DOIs
StatePublished - 2014

Bibliographical note

Publisher Copyright:
© Springer Science+Business Media New York 2014.

Keywords

  • Cytokines
  • Interleukin-15
  • Natural killer cells

Fingerprint

Dive into the research topics of 'Cytokine activation of natural killer cells'. Together they form a unique fingerprint.

Cite this